Quoin Pharmaceuticals Ltd. Shares Outstanding (Cover Page)
Quoin Pharmaceuticals Ltd. (QNRX) had Shares Outstanding (Cover Page) of 70.29 million shares as of 2026-08-12, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-12: Entity Common Stock, Shares Outstanding 70.29M shares.
- 2021-12-31: Entity Common Stock, Shares Outstanding 3.35B shares.
- 2020-12-31: Entity Common Stock, Shares Outstanding 390.95M shares.
- 2019-12-31: Entity Common Stock, Shares Outstanding 224.09M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 70.29M shares 10-Q · filed 2026-08-14 |
| 2021-12-31 | 3.35B shares 20-F · filed 2022-04-14 |
| 2020-12-31 | 390.95M shares 20-F · filed 2021-03-29 |
| 2019-12-31 | 224.09M shares 20-F · filed 2020-04-03 |
| 2018-12-31 | 130.41M shares 20-F · filed 2019-03-18 |
| 2017-12-31 | 120.14M shares 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |